Apolipoprotein-mediated cellular cholesterol efflux

Biochimica et Biophysica Acta - Lipids and Lipid Metabolism

Volumn 1392, Issue 1, 1998, Pages 1-15

  Yokoyama, Shinji ^a  

^a NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN; CHOLESTEROL; LIPOPROTEIN; PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE;

CHOLESTEROL ESTERIFICATION; CHOLESTEROL METABOLISM; CHOLESTEROL SYNTHESIS; CHOLESTEROL TRANSPORT; HUMAN; LIPID METABOLISM; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW;

APOLIPOPROTEIN A-I; APOLIPOPROTEIN A-II; APOLIPOPROTEINS; BIOLOGICAL TRANSPORT; CHOLESTEROL; LIPOPROTEINS, HDL; MODELS, BIOLOGICAL;

EID: 0032550773     PISSN: 00052760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0005-2760(98)00032-0     Document Type: Review

References (135)

1. Brown M.S., Goldstein J.L. A receptor-mediated pathway for cholesterol homeostasis. Science. 232:1986;34-47.
2. Krieger M., Acton S., Ashkenas J., Pearson A., Penman M., Resnick D. Molecular flypaper, host defense, and atherosclerosis: structure, binding proteins, and function of macrophage scavenger receptors. J. Biol. Chem. 268:1993;4569-4572.
3. Acton S., Rigotti A., Landschulz K.T., Xu S., Hobbs H.H., Krieger M. Identification of scavenger receptor SR-BI as a high-density lipoprotein receptor. Science. 271:1996;518-520.
4. Björkhem I., Andersson O., Diczfalusy U., Sevastik B., Xiu R.-J., Duan C., Lund E. Atherosclerosis and sterol 27-hydroxylase: evidence for a role of this enzyme in elimination of cholesterol from human macrophages. Proc. Natl. Acad. Sci. U.S.A. 91:1994;8592-8596.
5. Babiker A., Andersson O., Lund E., Xiu R.-J., Deeb S., Reshef A., Leitersdorf E., Diczfalusy U., Björkhem I. Elimination of cholesterol in macrophages and endothelial cells by the sterol 27-hydroxylase mechanism: comparison with high density lipoprotein-mediated reverse cholesterol transport. J. Biol. Chem. 272:1997;26253-26261.
6. Brown M.S., Goldstein J.L. The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription. Cell. 89:1997;331-340.
7. Murphy J.R. Erythrocyte metabolism: III. Relationship of energy metabolism and serum factors to the osmotic fragility following incubation. J. Lab. Clin. Med. 60:1962;86-109.
8. Glomset J.A. The lecithin:cholesterol acyltransferase reaction. J. Lipid Res. 9:1968;155-167.
9. Ho Y.K., Brown M.S., Goldstein J.L. Hydrolysis and excretion of cytoplasmic cholesterol esters by macrophages: stimulation by high density lipoprotein and other agents. J. Lipid Res. 21:1980;391-398.
10. Gordon D.J., Rifkind B.M. High density lipoprotein - The clinical implications of recent studies. New Engl. J. Med. 321:1989;1311-1316.
11. Fielding C.J., Fielding P.E. Molecular physiology of reverse cholesterol transport. J. Lipid Res. 36:1995;211-228.
12. Phillips M.C., Johnson W.J., Rothblat G.H. Mechanism and consequence of cellular cholesterol exchange and transfer. Biochim. Biophys. Acta. 906:1987;223-276.
13. Johnson W.J., Mahlberg F.H., Rothblat G.H., Phillips M.C. Cholesterol transport between cells and high density lipoproteins. Biochim. Biophys. Acta. 1085:1991;273-298.
14. Daniels R.J., Guertler L.S., Parker T.S., Steinberg D. Studies on the rate of efflux of cholesterol from cultured human skin fibroblasts. J. Biol. Chem. 256:1981;4978-4983.
15. Johnson W.J., Bamberger M.J., Latta R.A., Rapp P.E., Phillips M.C., Rothblat G.H. The bidirectional flux of cholesterol between cells and lipoproteins: effects of phospholipid depletion of high density lipoprotein. J. Biol. Chem. 261:1986;5766-5776.
16. Johnson W.J., Mahlberg F.H., Chacko G.K., Phillips M.C., Rothblat G.H. The influence of cellular and lipoprotein cholesterol contents on the efflux of cholesterol between fibroblasts and high density lipoprotein. J. Biol. Chem. 263:1988;14099-14106.
17. Fielding C.J., Fielding P.E. Evidence for a lipoprotein carrier in human plasma catalyzing sterol efflux from cultured fibroblasts and its relationship to lecithin: cholesterol acyltransferase. Proc. Natl. Acad. Sci. U.S.A. 78:1981;3911-3914.
18. Ko K.W.S., Ohnishi T., Yokoyama S. Triglyceride transfer is required for net cholesteryl ester transfer between lipoproteins in plasma by lipid transfer protein. J. Biol. Chem. 269:1994;28206-28213.
19. Huang Y., von Eckerdstein A., Wu S., Assmann G. Cholesterol efflux, cholesterol esterification, and cholesterol ester transfer by LpA-I and LpA-I/A-II in native plasma. Arterioscler. Thromb. Vasc. Biol. 15:1995;1412-1418.
20. Czarnecka H., Yokoyama S. Regulation of cellular cholesterol efflux by lecithin:cholesterol acyltransferase reaction through nonspecific lipid exchange. J. Biol. Chem. 271:1996;2023-2028.
21. Rothblat G.H., Phillips M.C. Mechanism of cholesterol efflux from cells: effects of acceptor structure and concentration. J. Biol. Chem. 257:1982;4775-4782.
22. Gold J.C., Phillips M.C. Effects of membrane lipid composition on the kinetics of cholesterol exchange between lipoproteins and different species of red blood cells. Biochim. Biophys. Acta. 1027:1990;85-92.
23. Kilsdonk E.P.C., Dorsman A.N.R.D., van Gent T., van Tol A. Effect of phospholipid fatty acid composition of endothelial cells on cholesterol efflux rates. J. Lipid Res. 33:1992;1373-1382.
24. Davidson W.S., Lund-Katz S., Johnson W.J., Anantharamaiah G.M., Palgunachari M.N., Segrest J.P., Rothblat G.H., Phillips M.C. The influence of apolipoprotein structure on the efflux of cellular free cholesterol to high density lipoprotein. J. Biol. Chem. 269:1994;22975-22982.
25. Lagrost L., Dengremont C., Athias A., de Geitere C., Fruchart J.-C., Lallemant C., Gambert P., Castro G. Modulation of cholesterol efflux from Fu5AH hepatoma cells by the apolipoprotein content of high density lipoprotein particles: particles containing various proportions of apoA-I and apoA-II. J. Biol. Chem. 270:1995;13004-13009.
26. Davidson W.S., Gillote K.L., Lund-Katz S., Johnson W.J., Rothblat G.H., Phillips M.C. The effect of high-density lipoprotein phospholipid acyl chain composition on the efflux of cellular free cholesterol. J. Biol. Chem. 270:1995;5882-5890.
27. Davidson W.S., Rodrigueza W.V., Lund-Katz S., Johnson W.J., Rothblat G.H., Phillips M.C. Effects of acceptor particle size on the efflux of cellular free cholesterol. J. Biol. Chem. 270:1995;17106-17113.
28. Gillotte K.L., Davidson W.S., Lund-Katz S., Rothblat G.H., Phillips M.C. Apolipoprotein A-I structural modification and the functionality of reconstituted high density lipoprotein particles in cellular cholesterol efflux. J. Biol. Chem. 270:1996;17106-17113.
29. Brinton E.A., Oram J.F., Chen C.-H., Albers J.J., Bierman E.L. Binding of high density lipoprotein to cultured fibroblasts after chemical alteration of apoprotein amino acid residues. J. Biol. Chem. 261:1986;495-503.
30. Oram J.F., Johnson C.J., Brown T.A. Interaction of high density lipoprotein with its receptor on cultured fibroblasts and macrophages: evidence for reversible binding at the cell surface without internalization. J. Biol. Chem. 262:1987;2405-2410.
31. Duel B.P., Oram J.F., Bierman E.L. Nonenzymatic glycosylation of HDL and impaired HDL-receptor-mediated cholesterol efflux. Diabetes. 40:1991;377-384.
32. Mendez A., Oram J.F. Limited proteolysis of high density lipoprotein abolishes its interaction with cell-interface binding site that promote cholesterol efflux. Biochim. Biophys. Acta. 1346:1997;285-299.
33. Karlin J.B., Johnson W.J., Benedict C.R., Chacko G.K., Phillips M.C., Rothblat G.H. Cholesterol flux between cells and high density lipoprotein: lack of relationship to specific binding of the lipoprotein to the cell surface. J. Biol. Chem. 262:1987;12557-12564.
34. Mendel C.M., Kunitake S.T. Cell-surface binding site for high density lipoproteins do not mediate efflux of cholesterol from human fibroblasts in tissue culture. J. Lipid Res. 29:1988;1171-1178.
35. Graham D.L., Oram J.F. Identification and characterization of a high density lipoprotein-binding protein in cell membranes by ligand blotting. J. Biol. Chem. 262:1987;7439-7442.
36. McKnight G.L., Reasoner J., Gilbert T., Sundquist K.O., Hokland B., McKernan P.A., Champagne J., Johnson C.J., Bailey M.C., Holly R., O'Hara P.J., Oram J.F. Cloning and expression of a cellular high density lipoprotein-binding protein that is up-regulated by cholesterol loading of cells. J. Biol. Chem. 267:1992;12131-12141.
37. Hokland B., Mendez A.J., Oram J.F. Cellular localization and characterization of proteins that bind high density lipoprotein. J. Lipid Res. 33:1992;1335-1342.
38. Ji Y., Jian B., Wang N., Sun Y., Moya M.d.l.L., Phillips M.C., Rothblat G.H., Swaney J.B., Tall A.R. Scavenger receptor BI promotes high density lipoprotein-mediated cellular cholesterol efflux. J. Biol. Chem. 272:1997;20982-20985.
39. Slotte J.P., Oram J.F., Bierman E.L. Binding of high density lipoproteins to cell receptors promotes translocation of cholesterol from intracellular membranes to the cell surface. J. Biol. Chem. 262:1987;12904-12907.
40. Aviram M., Bierman E.L., Oram J.F. High density lipoprotein stimulates sterol translocation between intracellular and plasma membrane pools in human monocyte-derived macrophages. J. Lipid Res. 30:1989;65-76.
41. Oram J.F., Mendez A.J., Slotte J.P., Johnson T.F. High density lipoprotein apolipoproteins mediate removal of sterol from intracellular pools but not from plasma membranes of cholesterol-loaded fibroblasts. Arterioscler. Thromb. 11:1991;403-414.
42. Johnson W.J., Fischer R.T., Phillips M.C., Rothblat G.H. Efflux of newly synthesized cholesterol and biosynthetic sterol intermediates from cells: evidence on acceptor type and on enrichment of cells with cholesterol. J. Biol. Chem. 270:1995;25037-25046.
43. Mendez A.J., Oram J.F., Bierman E.L. Protein kinase C as a mediator of high density lipoprotein receptor-dependent efflux of intracellular cholesterol. J. Biol. Chem. 266:1991;10104-10111.
44. Theret N., Delbart C., Aguie G., Fruchart J.C., Vassaux G., Ailhaud G. Cholesterol efflux from adipose cells is coupled to diacylglycerol production and protein kinase C activation. Biochem. Biophys. Res. Commun. 173:1990;1361-1368.
45. Darbon J.-M., Tournier J.-F., Tauber J.-P., Bayard F. Possible role of protein phosphorylation in the mitogenic effect of high density lipoproteins on cultures vascular endothelial cells. J. Biol. Chem. 261:1986;8002-8008.
46. Voyno-Yasenetskaya T.A., Dobbs L.G., Erickson S.K., Hamilton R.L. Low density lipoprotein- and high density lipoprotein-mediated signal transduction and exocytosis in alveolar type II cells. Proc. Natl. Acad. Sci. U.S.A. 90:1993;4256-4260.
47. Walter M., Reinecke H., Nofer J.-R., Seedorf U., Assmans G. HDL3 stimulates multiple signaling pathways in human skin fibroblasts. Arterioslcer. Thromb. Vasc. Biol. 15:1995;1975-1986.
48. Castro G.R., Fielding C.J. Early incorporation of cell-derived cholesterol into pre-β-migrating high-density lipoprotein. Biochemistry. 27:1988;25-29.
49. Miida T., Fielding C.J., Fielding P.E. Mechanism of transfer of LDL-derived free cholesterol to HDL subfraction in human plasma. Biochemistry. 29:1990;10469-10474.
50. Segrest J.P., Jackson R.L., Morrisett J.D., Gotto A.M. A molecular theory of lipid-protein interaction in the plasma apolipoproteins. FEBS Lett. 38:1974;247-253.
51. McLachlan A.D. Repeated helical pattern in apolipoprotein-A-I. Nature. 267:1977;465-466.
52. Fitch W.M. Phylogenies constrained by the crossover process as illustrated by human hemoglobins and a thirteen-cycle, eleven-amino-acid repeat in human apolipoprotein A-I. Genetics. 86:1977;623-644.
53. Kaiser E.T., Kézdy F.J. Secondary structures of proteins and peptides in amphiphilic environments (a review). Proc. Natl. Acad. Sci. U.S.A. 80:1983;1137-1143.
54. Segrest J.P., Jones M.K., De Loof H., Brouillette C.G., Venkatachalapachi Y.V., Anantharamaiah G.M. The amphipathic helix in the exchangeable apolipoproteins: a review of secondary structure and function. J. Lipid Res. 33:1992;141-166.
55. Yokoyama S., Fukushima D., Kupferberg J.P., Kézdy F.J., Kaiser E.T. The mechanism of activation of lecithin: cholesterol acyltransferase by apolipoprotein A-I and an amphiphilic peptide. J. Biol. Chem. 255:1980;7333-7339.
56. Fukushima D., Yokoyama S., Kroon D.J., Kézdy F.J., Kaiser E.T. Chain length-function correlation of amphiphilic peptides: Synthesis and surface properties of a tetratetracontapeptide segment of apolipoprotein A-I. J. Biol. Chem. 255:1980;10651-10657.
57. Emmanuel F., Steinmetz A., Rosseneu M., Brasseur R., Gosselet N., Attenot F., Cuiné S., Séguret S., Latta M., Fruchart J.-C., Denéfle P. Identification of specific amphipathic α-helical sequence of human apolipoprotein A-IV involved in lecithin:cholesterol acyltransferase activation. J. Biol. Chem. 269:1994;29883-29890.
58. Sigler G.F., Soutar A.K., Smith L.C., Gotto A.M.J., Sparrow J.T. The solid phase synthesis of a protein activator for lecithin-cholesterol acyltransferase corresponding to human plasma apoC-I. Proc. Natl. Acad. Sci. U.S.A. 73:1976;1422-1426.
59. Zorich N., Jonas A., Pownall H.J. Activation of lecithin cholesterol acyltransferase by human apolipoprotein E in discoidal complexes with lipids. J. Biol. Chem. 260:1985;8831-8837.
60. Tajima S., Yokoyama S., Yamamoto A. Mechanism of action of lipoprotein lipase on triolein particles: effect of apolipoprotein C-II. J. Biochem. 96:1984;1753-1767.
61. Funahashi T., Yokoyama S., Yamamoto A. Association of apolipoprotein E with the low density lipoprotein receptor-demonstration of its cooperativity on the lipid microemulsion particles. J. Biochem. 105:1989;582-587.
62. Hara H., Yokoyama S. Interaction of free apolipoprotein with macrophages: formation of high density lipoprotein-like lipoproteins and reduction of cellular cholesterol. J. Biol. Chem. 266:1991;3080-3086.
63. Hara H., Hara H., Komaba A., Yokoyama S. α-Helix requirement for free apolipoproteins to generate HDL and to induce cellular lipid efflux. Lipids. 27:1992;302-304.
64. Komaba A., Li Q., Hara H., Yokoyama S. Resistance of smooth muscle cells to assembly of high density lipoproteins with extracellular free apolipoproteins and to reduction of intracellularly accumulated cholesterol. J. Biol. Chem. 267:1992;17560-17566.
65. Bielicki J.K., Johnson W.J., Weinberg R.B., Glick J.M., Rothblat G.H. Efflux of lipid from fibroblasts to apolipoproteins: dependence on elevated levels of cellular unesterified cholesterol. J. Lipid Res. 33:1992;1699-1709.
66. Forte T.M., Goth-Goldstein R., Nordhausen R.W., McCall M.R. Apolipoprotein A-I-cell membrane interaction: extracellular assembly of heterogeneous nascent HDL particles. J. Lipid Res. 34:1993;317-324.
67. Forte T.M., Bielicki J.K., Goth-Goldstein R., Selmek J., McCall M.R. Recruitment of cell phospholipid and cholesterol by apolipoproteins A-I and A-II: formation of nascent apolipoprotein-specific HDL that differ in size, phospholipid composition, and reactivity with LCAT. J. Lipid Res. 36:1995;148-157.
68. Forte T.M., Bielicki J.K., Knoff L., McCall M.R. Structural relationships between nascent apoA-I-containing particles that are extracellularly assembled in cell culture. J. Lipid Res. 37:1996;1076-1085.
69. Mendez A., Anantharamaiah G.M., Segrest J.P., Oram J.F. Synthetic amphipathic helical peptides that mimic apolipoprotein A-I in clearing cellular cholesterol. J. Clin. Invest. 94:1994;1698-1705.
70. Yancey P.G., Bielicki J.K., Johnson W.J., Lund-Katz S., Palgunachari M.N., Anantharamaiah G.M., Segrest J.P., Phillips M.C., Rothblat G.H. Efflux of cellular cholesterol and phospholipid to lipid-free apolipoproteins and class A amphipathic peptides. Biochemistry. 34:1995;7955-7965.
71. Li Q., Komaba A., Yokoyama S. Cholesterol is poorly available for free apolipoprotein-mediated cellular lipid efflux from smooth muscle cells. Biochemistry. 32:1993;4597-4603.
72. Li Q., Tsujita M., Yokoyama S. Selective down-regulation by protein kinase C inhibitors of apolipoprotein-mediated cholesterol efflux in macrophages. Biochemistry. 36:1997;12045-12052.
73. Czarnecka H., Yokoyama S. Lecithin:cholesterol acyltransferase reaction on cellular lipid released by free apolipoprotein-mediated efflux. Biochemistry. 34:1995;4385-4392.
74. Tajima S., Yokoyama S., Yamamoto A. Effect of lipid particle size on association of apolipoproteins with lipid. J. Biol. Chem. 258:1983;10073-10082.
75. Yokoyama S., Kawai Y., Tajima S., Yamamoto A. Behavior of human apolipoprotein E in aqueous solutions and at interfaces. J. Biol. Chem. 260:1985;16375-16382.
76. Okabe H., Yokoyama S., Yamamoto A. Modulation of cholesterol microenvironment with apolipoproteins induced by the presence of cholesteryl ester in lipid microemulsion. J. Biochem. 104:1988;141-148.
77. Lagocki P.A., Scanu A.M. In vitro modification of the apolipoprotein composition of high density lipoprotein: displacement of apolipoprotein A-I from high density lipoprotein by apolipoprotein A-II. J. Biol. Chem. 255:1980;3701-3706.
78. Castro G.R., Fielding C.J. Evidence for the distribution of apolipoprotein E between lipoprotein classes in human normocholesterolemic plasma and for the origin of unassociated apolipoprotein E (Lp-E). J. Lipid Res. 25:1984;58-67.
79. Sloop C.H., Dory L., Roheim P.S. Interstitial fluid lipoproteins. J. Lipid Res. 28:1987;225-237.
80. Lefevre M., Sloop C.H., Roheim P.S. Characterization of dog prenodal peripheral lymph lipoproteins. Evidence for the peripheral formation of lipoprotein-unassociated apoA-I with slow pre-β electrophoretic mobility. J. Lipid Res. 29:1988;1139-1148.
81. Liang H.-Q., Rye K.-A., Barter P.J. Cycling of apolipoprotein A-I between lipid-associated and lipid-free pools. Biochim. Biophys. Acta. 1257:1995;31-37.
82. Asztalos B.F., Roheim P.S. Presence and formation of 'free apolipoprotein A-I-like' particles in human plasma. Arterioscler. Thromb. Vasc. Biol. 15:1995;1419-1423.
83. Bisgaier C.L., Sachdev O.P., Megna L., Glickman R.M. Distribution of apolipoprotein A-IV in human plasma. J. Lipid Res. 26:1985;11-25.
84. Lagrost L., Gambert P., Boquillon M., Lallemant C. Evidence for high density lipoproteins as the major apolioprotein A-IV-containing fraction in normal human serum. J. Lipid Res. 30:1989;1525-1534.
85. Weinberg R.B., Spector M.S. Human apolipoprotein A-IV: displacement from the surface of triglyceride-rich particles by HDL2-associated C-apoproteins. J. Lipid Res. 26:1985;26-37.
86. Pussinen P., Juahiainen M., Metso J., Tyynelä J., Ehnholm C. Pig plasma phospholipid transfer protein facilitates HDL interconversion. J. Lipid Res. 36:1995;975-985.
87. Clay M.A., Newnham H.H., Forte T.M., Barter P.I. Cholesteryl ester transfer protein and hepatic lipase activity promote shedding of apo A-I from HDL and subsequent formation of discoidal HDL. Biochim. Biophys. Acta. 1124:1992;52-58.
88. Liang H.-Q., Rye K.-A., Barter P.J. Dissociation of lipid-free apolipoprotein A-I from high density lipoproteins. J. Lipid Res. 35:1994;1187-1199.
89. Reichl D., Smons L.A., Myant N.B., Pflug J.J., Mills G.L. The lipids and lipoproteins of human peripheral lymph, with observations on the transport of cholesterol from plasma and tissues into lymph. Clin. Sci. Mol. Med. 45:1973;313-329.
90. Reichl D., Forte T.M., Hong J.-L., Rudra D.N., Pflug J. Human lymphedema fluid lipoproteins: particle size, cholesterol and apolipoprotein distributions, and electron microscopic structure. J. Lipid Res. 26:1985;1399-1411.
91. Sloop C.H., Dory L., Hamilton R., Krause B.R., Roheim P.S. Characterization of dog peripheral lymph lipoproteins: the presence of a disc-shaped 'nascent' high density lipoprotein. J. Lipid Res. 24:1983;1429-1440.
92. Reichl D., Sterchi J.M. Human peripheral lymph lipoproteins are enriched in sphingomyelin. Biochim. Biophys. Acta. 1127:1992;28-32.
93. Kunitake S.T., La Sala K.L., Kane J.P. Apolipoprotein A-I-containing lipoproteins with pre-beta electrophoretic mobility. J. Lipid Res. 26:1985;549-555.
94. Hara H., Yokoyama S. Role of apolipoproteins in cholesterol efflux from macrophages to lipid microemulsion: proposal of putative model for preβ high density lipoprotein pathway. Biochemistry. 31:1992;2040-2046.
95. Asztalos B., Zhang W., Roheim P.S., Wong L. Role of free apolipoprotein A-I in cholesterol efflux: Formation of pre-α-migrating high-density lipoprotein particles. Arterioscler. Thromb. Vasc. Biol. 17:1997;1630-1636.
96. Miida T., Kawano M., Fielding C.J., Fielding P.E. Regulation of the concentration of preβ high density lipoprotein in normal plasma by cell membranes and lecithin-cholesterol acyltransferase activity. Biochemistry. 31:1992;11112-11117.
97. Huang Y., von Eckardstein A., Wu S., Maeda N., Assmann G. A plasma lipoprotein containing only apolipoprotein E and with γ mobility on electrophoresis releases cholesterol from cells. Proc. Natl. Acad. Sci. U.S.A. 91:1994;1834-1838.
98. 1-HDL. Biochim. Biophys. Acta. 1301:1996;255-262.
99. Jiang X.-c., Francone O.L., Bruce C., Milne R., Mar J., Walsh A., Breslow J., Tall A.R. Increased prebeta-high density lipoprotein, apolipoprotein AI, and phospholipid in mice expressing the human phospholipid transfer protein and human apolipoprotein AI transgenes. J. Clin. Invest. 96:1996;2373-2380.
100. Dusserre E., Bourdillon M.C., Pulcini T., Berthezene F. Decrease in high density lipoprotein binding sites is associated with decrease in intracellular cholesterol efflux in differentiated aortic smooth muscle cells. Biochim. Biophys. Acta. 1212:1994;235-244.
101. Francis G.A., Knopp R.H., Oram J.F. Defective removal of cellular cholesterol and phospholipids by apolipoprotein A-I in Tangier disease. J. Clin. Invest. 96:1995;78-87.
102. Remaley A.T., Schumacher U.K., Stonik J.A., Farsi B.D., Nazih H.B., Brewer H.B.J. Decreased reverse cholesterol transport from Tangier disease fibroblasts: acceptor specificity and effect of brefeldin on lipid efflux. Arterioscler. Thromb. Vasc. Biol. 17:1997;1813-1821.
103. Kuwano M., Miida T., Fielding C.J., Fielding P.E. Quantitation of preβ-HDL and nonspecific components of the total efflux of cellular cholesterol and phospholipid. Biochemistry. 32:1993;5025-5028.
104. Li Q., Czarnecka H., Yokoyama S. Involvement of cellular surface factor(s) in lipid-free apolipoprotein-mediated cellular cholesterol efflux. Biochim. Biophys. Acta. 1259:1995;227-234.
105. Yokoyama S., Yamamoto A., Kurasawa T. A little more information about aggravation of probucol-induced HDL-reduction by clofibrate. Atherosclerosis. 70:1988;179-181.
106. Tsujita M., Yokoyama S. Selective inhibition of free apolipoprotein-mediated cellular lipid efflux by probucol. Biochemistry. 35:1996;13011-13020.
107. Mendez A.J. Monensin and brefeldin A inhibit high density lipoprotein-mediated cholesterol efflux from cholesterol-enriched cells: implication for intracellular cholesterol transport. J. Biol. Chem. 270:1995;5891-5900.
108. Mendez A.J., Uint L. Apolipoprotein-mediated cellular cholesterol and phospholipid efflux depend on a functional Golgi apparatus. J. Lipid Res. 37:1996;2510-2524.
109. L. Urbani, R.D. Simoni, Cholesterol and vesicular stomatitis virus G protein take separate routes from the endoplasmic reticulum to the plasma membrane, J. Biol. Chem. (1990) 1919-1923.
110. Liscum L., Dahl N.K. Intracellular cholesterol transport. J. Lipid Res. 33:1992;1239-1254.
111. Liscum L., Underwood K.W. Intracellular cholesterol transport and compartmentation. J. Biol. Chem. 270:1995;15443-15446.
112. Middleton A., Middleton B. Elevation of cyclic AMP in human skin fibroblasts results in increased capacity for HDL binding. Biochim. Biophys. Acta. 1302:1996;84-92.
113. Smith J.D., Miyata M., Ginsberg M., Grigaux C., Shmookler E., Plump A.S. Cyclic AMP induces apolipoprotein E binding activity and promotes cholesterol efflux from macrophage cell line to apolipoprotein acceptors. J. Biol. Chem. 271:1996;30647-30655.
114. Xu S., Laccotripe M., Huang X., Rigotti A., Zannis V., Krieger M. Apolipoprotein of HDL can directly mediate binding to the scavenger receptor SR-B1, an HDL receptor that mediates selective lipid uptake. J. Lipid Res. 38:1997;1289-1298.
115. J.A. Glomset, G. Assmann, E. Gjone, K.R. Norum, Lecithin: cholesterol acyltransferase deficiency and fish eye disease, in: C.R. Sciver, A.L. Beaudet, W.S. Sly, D. Valles (Eds.), The Metabolic and Molecular Bases of Inherited Disease, 7th edn., Health Profession Division McGraw-Hill, New York, 1995, pp. 1933-1952.
116. Simon J.B., Scheig R. Serum cholesterol esterification in liver disease. New Engl. J. Med. 283:1970;841-846.
117. Scherer R., Ruhenstroth-Bauer G. Untersuchung der Lecithin-Cholesterol-Acyltransferase-Activität im Serum von drei Patienten mit Tangier-Krankheit (Hyp-alpha-Lipoproteinämie). Klin. Wschr. 51:1973;1059-1061.
118. Ohtaki S., Nakagawa N., Kida H., Nakamura H., Tsuda K., Yokoyama S., Yamamura T., Tajima S., Yamamoto A. A Japanese family with high density lipoprotein deficiency. Atherosclerosis. 49:1983;79-88.
119. Cheung M.C., Wang D., Lum K.D., Albers J.J. Cholesterol esterification by lecithin-cholesterol acyltransferase in A-I-free plasma. Biochim. Biophys. Acta. 962:1988;258-264.
120. G. Assmann, A. von Eckardstein, H.B.J. Brewer, Familial high density lipoprotein deficiency: tangier disease, in: C.R. Scriver, A.L. Beaudet, W.S. Sly, D. Valles (Eds.), The Metabolic and Molecular Bases of Inherited Disease, Health Profession Division, McGraw-Hill, New York, 1995, pp. 2053-2072.
121. Sviridov D., Fidge N. Efflux of intracellular versus plasma membrane cholesterol in HepG cells: different availability and regulation by apolipoprotein A-I. J. Lipid Res. 36:1995;1887-1896.
122. Li Q., Yokoyama S. Independent regulation of cholesterol incorporation into free apolipoprotein-mediated cellular lipid efflux in rat smooth muscle cells. J. Biol. Chem. 270:1995;26216-26223.
123. Inaba T., Gotoda T., Shimano H., Shimada M., Harada K., Kozaki K., Watanabe Y., Hoh E., Motoyoshi K., Yazaki Y., Yamada N. Platelet-derived growth factor induces c-fms and scavenger genes in vascular smooth muscle cells. J. Biol. Chem. 267:1992;13107-13112.
124. Walter M., Reinecke H., Gerdes U., Nofer J.-R., Höbbel G., Seedort U., Assmann G. Defective regulation of phosphatidylcholine-specific phospholipases C and D in a kindred with Tangier disease: evidence for the involvement of phosphatidylcholine breakdown in HDL-mediated cholesterol efflux mechanisms. J. Clin. Invest. 98:1996;2315-2323.
125. Francis G.A., Mendez A.J., Bierman E.L., Heinecke J.W. Oxidative tyrosylation of high density lipoprotein by peroxidase enhances cholesterol removal from cultured fibroblasts and macrophage foam cells. Proc. Natl. Acad. Sci. U.S.A. 90:1993;6631-6635.
126. Francis G.A., Oram J.F., Heinecke J.W., Bierman E.L. Oxidative tyrosylation of HDL enhances the depletion of cellular cholesteryl esters by a mechanism independent of passive sterol desorption. Biochemistry. 35:1996;15188-15197.
127. Rogler G., Trümbach B., Klima B., Lackner K.J., Schmitz G. HDL-mediated efflux of intracellular cholesterol is impaired in fibroblasts from Tangier disease patients. Arterioscler. Thromb. Vasc. Biol. 15:1995;683-690.
128. Smart E.J., Ying Y.-s., Donzell W.C., Anderson R.G.W. A role of caveolin in transport of cholesterol from endoplasmic reticulum to plasma membrane. J. Biol. Chem. 271:1996;29427-29435.
129. Fielding P.E., Fielding C.J. Plasma membrane caveolae mediate the efflux of cellular free cholesterol. Biochemistry. 34:1995;14288-14292.
130. Fielding C.J., Fielding P.E. Intracellular cholesterol transport. J. Lipid Res. 38:1997;1503-1521.
131. Oram J.F., Yokoyama S. Apolipoprotein-mediated removal of cellular cholesterol and phospholipids. J. Lipid Res. 37:1996;2473-2491.
132. Mendez A.J. Cholesterol efflux mediated by apolipoproteins is an active cellular process distinct from efflux mediated by passive diffusion. J. Lipid Res. 38:1997;1807-1821.
133. Vaisman B.L., Klein H.-G., Rouis M., Bérard A.M., Kindt M.R., Talley G.D., Meyn S.M., Hoyt R.F., Marcovina S.M., Albers J.J., Hoeg J.M., Brewer H.B., Santamarina-Fojo S. Overexpression of human lecithin cholesterol acyltransferase leads to hyperalphalipproteinemia in transgenic mice. J. Biol. Chem. 270:1995;12269-12275.
134. Francone O.L., Haghpassand M., Bennett J.A., Royer L., McNeish J. Expression of human lecithin: cholesterol acyltransferase in transgenic mice: effects on cholesterol efflux, esterification and transport. J. Lipid Res. 38:1997;813-822.
135. Zhang W.-Y., Gaynor P.M., Kruth H.S. Apolipoprotein E produced by human monocyte-derived macrophages mediates cholesterol efflux that occurs in the absence of added cholesterol acceptors. J. Biol. Chem. 271:1996;28641-28646.